Guardant Health (GH) Cash & Current Investments (2017 - 2026)

Guardant Health has reported Cash & Current Investments for 10 years, with the latest figure at $1.1 billion in Q2 2026.

• Quarterly Cash & Current Investments rose 67.45% year-over-year to $1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (up 67.45% YoY) and the FY2025 annual result came in at $1.2 billion, up 43.05% from the prior year.
• Cash & Current Investments eased to $1.1 billion in Q2 2026 per GH's latest filing, from $1.1 billion in the prior quarter.
• Over five years, Cash & Current Investments peaked at $1.2 billion in Q2 2023 and troughed at $580.0 million in Q3 2025.
• A 5-year average of $957.5 million and a median of $960.2 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2026: Cash & Current Investments plunged 52.35% in 2022, then soared 67.45% in 2026.
• Over 5 years, Cash & Current Investments stood at $1.0 billion in 2022, then advanced by 15.57% to $1.2 billion in 2023, then slipped by 28.12% to $840.0 million in 2024, then soared by 43.05% to $1.2 billion in 2025, then decreased by 12.33% to $1.1 billion in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $1.1 billion, $1.1 billion, and $1.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.